Yaz and Yasmin Birth Control Pill Settlement of 500 Cases Reported for $110 Million It was reported in Bloomberg on Friday that Bayer AG, the manufacturer of the blockbuster birth control drugs, Yaz and Yasmin has settled about 500 lawsuits arising out of blood clot injuries alleged to have been caused by the drugs. It [...]
Drospirenone-Containing Birth Control Pills Still Under Scrutiny
In a new drug safety communication posted today on the U.S. Food and Drug Administration’s website, the agency announced that preliminary results of a study involving 800,000 women suggest a 1.5-fold increase in the risk of blood clots for those women using drospirenone-containing birth-control pills, compared to those taking other forms of hormonal contraceptives. Popular [...]
Risk of Blood Clots Trigger FDA’s Review of Birth Control Pills
Following reports from two new studies claiming that birth control pills containing the progestin hormone, drospirenone, are more likely to pose a higher-than-expected risk of serious blood clots, the U.S. Food and Drug Administration issued a safety review of all drospirenone-containing birth control products. The expressed concern over drospirenone, which can be found specifically in [...]
Despite Yaz Lawsuits, Bayer Remains No. 1
Amid a flurry of Yaz lawsuits, Bayer Healthcare, eager to hold its top spot in the oral contraceptive market, launched a new birth control pill last year… Natazia. Bayer cleverly launched Yaz in 2006, promising that the new formulation birth control pill – a combination of ethinyl estradiol and drospirenone – not only prevented pregnancy [...]